Nav: Home

Restoring leg blood flow is better option than exercise for PAD patients

May 05, 2016

NASHVILLE, Tennessee, May 5, 2016 -- Restoring blood flow to the legs of patients with peripheral artery disease (PAD) may stop the progression of scarring in their leg muscles, according to preliminary research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology / Peripheral Vascular Disease 2016 Scientific Sessions.

PAD causes pain and fatigue while walking due to poor blood circulation in arteries that supply blood to the limbs. The decreased blood flow can lead to substantial scarring and damage in leg muscles. Moreover, there are currently no available treatments once the scarring has occurred. Supervised exercise therapy and revascularization procedures (which reopen or bypass blockages in the blood vessels) may help PAD patients walk further and longer, but it is not known if these treatments affect the scarring process.

Researchers looked at levels of transforming growth factor-beta (TGF-β1) -- a protein that promotes scarring -- and the amount of collagen (tough protein fibers found in scars) in calf muscle biopsies from patients with PAD severe enough to be considered for surgery. Six months later, they compared changes in biopsy results among 20 patients who underwent revascularization, 19 who participated in a supervised exercise program, and 17 who had no treatment. Among the findings:
  • Scarring factors - collagen fibers and TGF-β1 - increased in the exercise and control groups, but not in the revascularization group;

  • Patients in both the revascularization and exercise groups increased their maximum walking time on treadmill, before calf pain made it impossible to continue;

  • Only patients in the revascularization group improved the distance they could walk in six minutes.

Neither exercise nor revascularization treatment reversed scarring that had already taken place in the calf muscles. However, "increasing blood flow to the leg with revascularization procedures halted the progression of scarring and allowed the patients to walk longer and further," said Duy Ha, B.S., lead author of the study and a doctoral candidate in cellular and integrative physiology at the University of Nebraska Medical Center in Omaha. "This suggests that the long-term benefits to the health of leg muscles is better with revascularization than with exercise therapy alone. Unfortunately, not all patients are candidates for these procedures, which carry significant risks, and the treated vessels may get blocked again,"

"We hope that we can develop therapies that directly decrease TGF-β1 and its associated scarring in the leg muscles of PAD patients. Such new treatments, when used alone or along with revascularization and exercise, may maintain or enhance the ability of our patients to walk and live healthy lives," Ha said.
Co-authors are George Casale, Ph.D.; Alicia Luis; Kevin Harkins; Reagan Huber; Tanmayee Changalasetty, Ruby Hickman; Mina Hanna, M.S.; Stanley Swanson, B.S.; Holly DeSpiegelaere, R.N.; and Iraklis Pipinos, M.D. Author disclosures are on the abstract.

This study is funded by the National Heart Lung and Blood Institute, National Institute of Aging, and the Charles and Mary Heider Fund for Excellence in Vascular Surgery. The V.A. Nebraska and Western Iowa Health Care System provided additional support.

Note: Meeting presentation time is 6 p.m. CT, Thursday, May 5th, 2016.

Additional Resources:

The American Heart Association's Peripheral Artery Disease site
Daily Science News from the ATVB meeting
Follow the news on @HeartNews Twitter #ATVBPVDScience and check out all the news and information across AHA/ASA social media on our Social Media Hub.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at

American Heart Association

Related Peripheral Artery Disease Articles:

Stretching may reduce walking pain among peripheral artery disease patients
Wearing a splint to stretch calf muscles may enhance blood flow through clogged leg arteries.
Quality of care for peripheral artery disease is low
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling.
Aspirin therapy may not help patients with peripheral vascular disease, researchers find
Aspirin use may not provide cardiovascular benefits for patients who have peripheral vascular disease, an analysis by University of Florida Health researchers has found.
Decreasing cocaine use leads to regression of coronary artery disease
People who use cocaine regularly are at high risk of coronary artery disease.
New drug could help prevent artery disease in high-risk patients
According to the American Heart Association, approximately 2,200 Americans die each day from heart attacks, strokes and other cardiovascular diseases.
New peripheral artery disease guidelines emphasize medical therapy and structured exercise
Patients with peripheral artery disease (PAD) should be on a program of guideline-directed medical therapy (including antiplatelet drugs that thin blood and statins to lower cholesterol) and should participate in a structured exercise program.
Association between sugary diet and coronary artery disease
What connection is there between food and drink with added sugar and coronary artery disease?
Longer duration of dual antiplatelet therapy after stent placement improves outcomes for patients with peripheral arterial disease
In a study published online by JAMA Cardiology, Marco Valgimigli, M.D., Ph.D., of Bern University Hospital, Bern, Switzerland, and colleagues assessed the efficacy and safety of prolonged (24 months) vs short (6 months or less) dual antiplatelet therapy in patients with peripheral arterial disease undergoing percutaneous coronary intervention.
New therapy could treat poor blood circulation caused by peripheral artery disease
Bioengineers and physicians at the UC San Diego have developed a potential new therapy for critical limb ischemia, a condition that causes extremely poor circulation and leads to an estimated 230,000 amputations yearly in North America and Europe alone to prevent the spread of infection and tissue death.
New findings point to central nervous system role in painful diabetic peripheral nerve disease
Emerging evidence suggests that the central nervous system is a key contributor to the problem of painful peripheral nerve disease in people with diabetes, according to a special article in the February issue of PAINĀ®, the official publication of the International Association for the Study of Pain.

Related Peripheral Artery Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...